Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXC Technology
DXC
|
+$213M |
| 2 |
Altria Group
MO
|
+$206M |
| 3 |
ExxonMobil
XOM
|
+$105M |
| 4 |
Microsoft
MSFT
|
+$86.8M |
| 5 |
Meta Platforms (Facebook)
META
|
+$75.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$403M |
| 2 |
Home Depot
HD
|
+$164M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$160M |
| 4 |
Boeing
BA
|
+$127M |
| 5 |
Hewlett Packard
HPE
|
+$92.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.07% |
| 2 | Financials | 16.07% |
| 3 | Healthcare | 14.35% |
| 4 | Industrials | 10.62% |
| 5 | Consumer Discretionary | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
JASO
3676
DELISTED
JA Solar Holdings, Co., Ltd
JASO
| $172K | ﹤0.01% |
27,183
-1,195
| -4% | -$8.07K |
2014 Q4
10 quarters
|
|
|
DMTX
3677
DELISTED
Dimension Therapeutics, Inc
DMTX
| $172K | ﹤0.01% |
119,291
-26,605
| -18% | -$36.2K |
2016 Q1
5 quarters
|
|
3678
VNET Group
VNET
$1.26B
| $170K | ﹤0.01% |
33,985
+5,365
| +19% | +$29.1K |
2014 Q4
10 quarters
|
|
|
FNJN
3679
DELISTED
Finjan Holdings, Inc.
FNJN
| $170K | ﹤0.01% |
51,830
-41,946
| -45% | -$109K |
2015 Q3
7 quarters
|
|
3680
Perspective Therapeutics
CATX
$267M
| $168K | ﹤0.01% |
26,978
| – | – |
2013 Q2
16 quarters
|
|
3681
Nomura Holdings
NMR
$27.1B
| $168K | ﹤0.01% |
27,891
+1,281
| +5% | +$7.84K |
2013 Q2
16 quarters
|
|
|
AIFU
3682
AIFU Inc
AIFU
$67M
| $167K | ﹤0.01% |
49
-6
| -11% | -$20.8K |
2014 Q4
10 quarters
|
|
|
AMRB
3683
DELISTED
American River Bankshares
AMRB
| $166K | ﹤0.01% |
11,472
-1,453
| -11% | -$20.8K |
2015 Q4
6 quarters
|
|
3684
DELISTED
BioLife Solutions
BLFS
| $165K | ﹤0.01% |
69,384
| – | – |
2016 Q3
3 quarters
|
|
3685
Calumet Specialty Products
CLMT
$5.12B
| $165K | ﹤0.01% |
38,959
-9,349
| -19% | -$37.5K |
2013 Q2
16 quarters
|
|
3686
DELISTED
Titan Pharmaceuticals
TTNP
| $165K | ﹤0.01% |
24
-10
| -29% | -$93K |
2015 Q4
6 quarters
|
|
3687
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $165K | ﹤0.01% |
1,747
-35
| -2% | -$4.02K |
2013 Q2
16 quarters
|
|
3688
Zedge
ZDGE
$43M
| $164K | ﹤0.01% |
74,255
-1,981
| -3% | -$5.57K |
2016 Q2
4 quarters
|
|
3689
DELISTED
Volt Information Sciences, Inc.
VOLT
| $164K | ﹤0.01% |
41,675
| – | – |
2015 Q1
9 quarters
|
|
|
MARK
3690
DELISTED
Remark Holdings, Inc.
MARK
| $162K | ﹤0.01% |
5,790
| – | – |
2015 Q3
7 quarters
|
|
|
EMAN
3691
DELISTED
eMagin Corporation
EMAN
| $160K | ﹤0.01% |
65,621
| – | – |
2013 Q2
16 quarters
|
|
|
PTX
3692
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $160K | ﹤0.01% |
39,813
+2,418
| +6% | +$10.5K |
2013 Q2
16 quarters
|
|
3693
Hennessy Advisors
HNNA
$82.4M
| $159K | ﹤0.01% |
10,487
-7,809
| -43% | -$125K |
2016 Q3
3 quarters
|
|
3694
Live Ventures
LIVE
$23.5M
| $157K | ﹤0.01% |
14,842
-322
| -2% | -$4.05K |
2014 Q1
13 quarters
|
|
3695
Banco Bilbao Vizcaya Argentaria
BBVA
$143B
| $156K | ﹤0.01% |
18,734
+3,543
| +23% | +$28.6K |
2013 Q4
14 quarters
|
|
3696
WidePoint Corp
WYY
$64.7M
| $156K | ﹤0.01% |
34,082
| – | – |
2013 Q2
16 quarters
|
|
3697
DELISTED
Profire Energy, Inc
PFIE
| $155K | ﹤0.01% |
119,381
-8,600
| -7% | -$11.5K |
2014 Q2
12 quarters
|
|
3698
DELISTED
Molecular Templates, Inc.
MTEM
| $155K | ﹤0.01% |
2,397
-85
| -3% | -$6.68K |
2013 Q2
16 quarters
|
|
|
TMBR
3699
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
| $155K | ﹤0.01% |
22
+21
| +2,100% | +$183K |
2017 Q1
1 quarter
|
|
|
GSB
3700
DELISTED
GlobalSCAPE, Inc.
GSB
| $155K | ﹤0.01% |
29,423
| – | – |
2014 Q1
13 quarters
|
|
Similar funds
Geode Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Geode Capital Management held 4,218 positions worth $254B, up 4.3% from $244B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Geode Capital Management's Q2 2017 filing shows 134 new, 2,755 increased, 887 reduced and 134 closed positions. Its largest new stake was DXC Technology: 3,214,073 shares worth $213M. The largest sale was Yahoo Inc, an estimated $403M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2017 buy was DXC Technology: 3,214,073 shares worth $213M.
- Geode Capital Management added most to Altria Group in Q2 2017, an estimated $206M increase.
- Geode Capital Management's biggest Q2 2017 reduction was Home Depot, cutting an estimated $164M.
- Geode Capital Management fully exited Yahoo Inc in Q2 2017, selling an estimated $403M.
- Geode Capital Management's ten largest holdings make up 16% of its $254B portfolio in Q2 2017.
- Geode Capital Management opened 134 new positions and closed 134 in Q2 2017.
- Geode Capital Management's portfolio value rose 4.3% quarter-over-quarter to $254B.
Based on Geode Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.